Gemechu, Ashebir Debalike
Gebremedhin, Tsegaye Demeke
Andebiku, Andualem Assefa
Solomon, Fithamlak
Sorsa, Abebe
Article History
Received: 3 September 2022
Accepted: 14 November 2022
First Online: 24 November 2022
Declarations
:
: The study was approved by the Institutional Review board of Wolaita Sodo University, College of Health Science and Medicine, with protocol number CHSM/ERC/103, written on February 26, 2020. The study was also done as per the declaration of Helsinki. The benefits and purposes of the study were explained to the patients, and each participant provided written, informed consent. Confidentiality was maintained at all levels of the study by avoiding identifiers and using codes to identify patients. Participants’ involvement in the study was voluntary. Participants who did not wish to participate in the study or who wished to withdraw at any time were informed that they could do so without restriction.
: Not applicable.
: The authors declare that they have no conflicts interests.